On April 24, 2014 at the McCamish Pavillion, more than 900 seniors from across Georgia Tech will showcase their final senior design projects at the Capstone Design Expo. The Senior Design (Capstone Design) course, a culmination of undergraduate education, teaches students about the design process and allows them one last opportunity to truly take advantage of Georgia Tech’s numerous resources to launch their own venture, solve a social need, or work with an industry sponsor.

The 10 graduate students are discussing stem cell population analysis, when it’s time. Before they can continue the discussion, Todd McDevitt, the instructor, has to do one thing — turn on the TV.

Varian Medical Systems, Inc. announced it has signed an agreement with Velocity Medical Solutions, LLC to acquire certain assets of Velocity, a privately-held Atlanta-based developer of specialized software for cancer clinics.

Varian Medical Systems, Inc. announced it has signed an agreement with Velocity Medical Solutions, LLC to acquire certain assets of Velocity, a privately-held Atlanta-based developer of specialized software for cancer clinics.

The venomous sidewinder rattlesnake has always been able to kill you - but now could it help save you, too.

A new microfluidic method for evaluating drugs commonly used for preventing heart attacks has found that while aspirin can prevent dangerous blood clots in some at-risk patients, it may not be effective in all patients with narrowed arteries. The study, which involved 14 human subjects, used a device that simulated blood flowing through narrowed coronary arteries to assess effects of anti-clotting drugs.

Arthur E. Bergles, (78), of Centerville, Massachusetts, an accomplished Professor of Engineering, passed away Monday, March 17, 2014, of a malignant brain tumor.

Bob Nerem, Professor Emeritus at the George W. Woodruff School of Mechanical Engineering, has spent much of his long career exploring critical health-related topics such as blood flow in large arteries, the role of hemodynamics in the onset of atherosclerosis, and more recently tissue engineering and regenerative medicine.